I do believe they have a great product but I also believe they could manage things better for me a shareholder by simply communicating even a few breadcrumbs. When was the last time they said anything about lymph system formula or the combo pill or the share buyback or ROW strategy besides EU and China. I'm holding because I think we can be successful in spite of this incompetency. It's the EPA.
You can't be serious, that's easy to say "you should sell" from someone like you that bought most of your shares around $13 to $14 (post R/S). You have no idea what you are talking about. Try to say that to most shareholders that bought the shares around $65 (post R/S).
Market Data 
Markets 
AI
